Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 9 years
- Director since
- 2023
9 years of board service in total across 3 boards, counting each seat separately. Longest: Cue Biopharma Inc., 3 years.
Cue Biopharma Inc.
Director
Cognition Therapeutics Inc.
Director
Actuate Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 19, 2025 | Cognition Therapeutics Inc. | Option exercise | +7,729 | $0.84 | $6,492 |
| May 24, 2024 | Lantern Pharma Inc. | Open-market sale | −1,859 | $6.33 | $11,767 |
| May 24, 2024 | Lantern Pharma Inc. | Open-market sale | −13,888 | $6.33 | $87,911 |
| May 24, 2024 | Lantern Pharma Inc. | Open-market sale | −4,253 | $6.33 | $26,921 |
| May 23, 2024 | Lantern Pharma Inc. | Open-market sale | −930 | $6.25 | $5,813 |
| May 23, 2024 | Lantern Pharma Inc. | Open-market sale | −6,944 | $6.25 | $43,400 |
| May 23, 2024 | Lantern Pharma Inc. | Open-market sale | −2,126 | $6.25 | $13,288 |
| Nov 29, 2023 | Lantern Pharma Inc. | Open-market sale | −53,640 | $3.44 | $184,522 |
| Nov 29, 2023 | Lantern Pharma Inc. | Open-market sale | −91,708 | $3.44 | $315,476 |
| Nov 8, 2023 | Cognition Therapeutics Inc. | Grant or award | +500,095 | $1.05 | $525,100 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.